Regentis Biomaterials
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-06-30 | 2024-12-31 |
|---|---|---|---|
Cash | 7,378 | 189 | 229 |
Basic Shares | 5,179 | 5,179 | 5,179 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Net Income | -13,648 | 4,801 | -4,132 | -1,449 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,375 | -641 | -1,220 | -1,504 |
Cash | 7,378 | 229 | 345 | 1,240 |
Basic Shares | 5,179 | 5,179 | 4,929 | 4,929 |